APEIRON قرد

Contact

About

Apeiron Fund is a closed-end core buyout fund targeting a unique investment thesis. We acquire and rebrand Natura Cultivation facilities, Cookies brand dispensaries, and senior living portfolios into Avicenna Medical Centers, specializing in plant-based pharmaceuticals. This innovative approach addresses the polypharmacy pain point, offering a cost-effective solution with a $10 production cost yielding a 400% return. With a $1 billion fund size, a 10-year horizon, and a minimum investment of $20 million, we aim to achieve an 8% or higher cap rate. Our fee structure is investor-friendly, featuring 0% management fees, an 8% hurdle rate, a 2% catch-up, and a 20% carry. A 2% due diligence fee is required within 10 days of signing, available to qualified purchasers only.
Learn More

CloudPatch Club

 Top Stories

Programs

Contact us

Follow

Email Us

We're here to help! Send any questions you have over to us. We look forward to hearing from you.

Contact Us

Share by: